Tito R. Mendoza

Office of the Director — United States

Medicine · Health Sciences

72h-index23.3kcitations473works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer survivorship and care(163), Pain Management and Opioid Use(63), Palliative Care and End-of-Life Issues(62), Childhood Cancer Survivors' Quality of Life(60), Cancer Treatment and Pharmacology(58)

Publications472 total

Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System Tumor
2026Open Access
Figure S2 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Supplementary Data 1 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Figure S3 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Figure S4 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
Figure S1 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
2025Open Access
CTNI-66. CERN 09-02: A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA
Neuro-Oncology·2025Open Access
66. Type and Formulation of Antipsychotic Medications and Renal Impairment Impact on Severity of Neuroleptic Malignant Syndrome
Journal of the Academy of Consultation-Liaison Psychiatry·2025
Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden
Cancers·2025Open Access
Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report
Neuro-Oncology·2025· 6 citedOpen Access
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative
Neuro-Oncology·2025Open Access
Clinical Characteristics and Outcomes of Pediatric COVID-19 Encephalitis in Hispanic Patients (P1-10.002)
Neurology·2025
Clinical Characteristics and Outcomes of Infectious Encephalitis in Hispanic Pediatric Patients: A Retrospective Analysis (P7-10.006)
Neurology·2025
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review
JNCI Cancer Spectrum·2025Open Access
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study
Neuro-Oncology Advances·2025· 2 citedOpen Access
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).
UNC Libraries·2024Open Access
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
Quality of Life Research·2024· 2 citedOpen Access
NCOG-28. SERUM PROTEIN BIOMARKERS LINKED TO NEURODEGENERATIVE PROCESSES ARE ELEVATED IN GLIOMA PATIENTS AND ASSOCIATED WITH SEVERITY OF NEUROLOGIC SYMPTOMS
Neuro-Oncology·2024· 1 citedOpen Access
NCOG-27. HIGHER LEVELS OF SERUM ICAM-1 AND IL-10 ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION IN BOTH IDH-WILDTYPE AND IDH-MUTANT GLIOMA
Neuro-Oncology·2024· 1 citedOpen Access
Patient-reported outcomes in early phase trials for patients with myelodysplastic syndromes
Seminars in Hematology·2024· 3 cited
page 1 of 24Next →

Frequent Co-authors

Charles S. Cleeland(44), Xin Shelley Wang(11), Thomas M. Atkinson(7), Ethan Basch(7), Bryce B. Reeve(6), Deborah Schrag(6), Karen O. Anderson(6), Lori M. Minasian(5), Ann M. O’Mara(5), Antonia V. Bennett(5), Laura Sit(5), Lauren J. Rogak(5), Guadalupe R. Palos(5), Sandra A. Mitchell(4), Amylou C. Dueck(4), Deborah Watkins Bruner(4), Andrea Denicoff(4), Ibrahima Gning(4), Vicente Valero(4), Terri S. Armstrong(4)